index - CRCL-OncoPharmacologie

Manon Gouez, Amélie Rébillard, Amandine Thomas, Sabine Beaumel, Eva-Laure Matera, et al.. Combined effects of exercise and immuno-chemotherapy treatments on tumor growth in MC38 colorectal cancer-bearing mice. Frontiers in Immunology, 2024, 15, pp.1368550. ⟨10.3389/fimmu.2024.1368550⟩. ⟨hal-04479752⟩
Zhichong Wu, Kevin Thierry, Sophie Bachy, Xinyi Zhang, Pia Gamradt, et al.. Pericyte stem cells induce Ly6G ⁺ cell accumulation and immunotherapy resistance in pancreatic cancer. EMBO Reports, 2023, ⟨10.15252/embr.202256524⟩. ⟨hal-04047023⟩
Marine Leroux, Hana Bouazizi-Ben Messaoud, Céline Luquain-Costaz, Lars Jordheim, Pauline Le Faouder, et al.. Enriched PUFA environment of Leishmania infantum promastigotes promotes the accumulation of lipid mediators and favors parasite infectivity towards J774 murine macrophages. Lipids, 2023, 58 (2), pp.81-92. ⟨10.1002/lipd.12365⟩. ⟨hal-04158694⟩
Valentina Andretto, Mathieu Repellin, Marine Pujol, Eyad Almouazen, Jacqueline Sidi-Boumedine, et al.. Hybrid core-shell particles for mRNA systemic delivery. Journal of Controlled Release, 2023, 353, pp.1037-1049. ⟨10.1016/j.jconrel.2022.11.042⟩. ⟨hal-04082346⟩
Jérôme Guitton, Floriane Gavotto, Emeline Cros-Perrial, Lars Petter Jordheim, Christelle Machon. A Proposed Methodology to Deal with the Impact of In Vitro Cellular Matrix on the Analytical Performances of a Targeted Metabolomic LC-HRMS Method. International Journal of Molecular Sciences, 2023, 24 (4), pp.3770. ⟨10.3390/ijms24043770⟩. ⟨hal-04165175⟩
Lars Petter Jordheim. PARP Inhibitors and Proteins Interacting with SLX4. Cancers, 2023, 15, ⟨10.3390/cancers15030997⟩. ⟨hal-04164299⟩

Derniers manuscrits de l'équipe

Chiffres clés